| Year |
Citation |
Score |
| 2019 |
Russo A, Paret C, Alt F, Burhenne J, Fresnais M, Wagner W, Glaser M, Bender H, Huprich S, Harter PN, Filipski K, Lehmann N, Backes N, Roth L, Seidmann L, et al. Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor. International Journal of Molecular Sciences. 20. PMID 31480400 DOI: 10.3390/Ijms20174267 |
0.306 |
|
| 2018 |
Stieb S, Fischbeck S, Wagner W, Appels J, Wiewrodt D. High psychosocial burden in relatives of malignant brain tumor patients. Clinical Neurology and Neurosurgery. 170: 1-6. PMID 29709767 DOI: 10.1016/J.Clineuro.2018.04.023 |
0.586 |
|
| 2018 |
Neu MA, Tanyildizi Y, Wingerter A, Henninger N, El Malki K, Alt F, Doerr B, Schmidberger H, Stockinger M, Wagner W, Keweloh S, Brockmann MA, Russo A, Faber J. Susceptibility-weighted magnetic resonance imaging of cerebrovascular sequelae after radiotherapy for pediatric brain tumors. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 29605477 DOI: 10.1016/J.Radonc.2018.03.010 |
0.316 |
|
| 2017 |
Paret C, Russo A, Otto H, Mayer A, Zahnreich S, Wagner W, Samuel D, Scharnhorst D, Solomon DA, Dhall G, Wong K, Bender H, Alt F, Wingerter A, Neu MA, et al. Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy. Oncotarget. 8: 114210-114225. PMID 29371980 DOI: 10.18632/Oncotarget.23174 |
0.323 |
|
| 2016 |
Paret C, Theruvath J, Russo A, Kron B, El Malki K, Lehmann N, Wingerter A, Neu MA, Gerhold-Ay A, Wagner W, Sommer C, Pietsch T, Seidmann L, Faber J. Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy. Oncotarget. PMID 27825128 DOI: 10.18632/Oncotarget.13092 |
0.325 |
|
| 2016 |
Paret C, Theruvath J, Russo A, Kron B, ElMalki K, Lehmann N, Neu M, Gerhold-Ay A, Wagner W, Sommer C, Seidmann L, Faber J. Pnr-35Cns Hgnet-Bcor - Molecular Characterization And Identification Of Possible Therapeutic Targets Of A New Brain Tumor Entity. Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now067.30 |
0.303 |
|
| 2013 |
Constantini S, Mohanty A, Zymberg S, Cavalheiro S, Mallucci C, Hellwig D, Ersahin Y, Mori H, Mascari C, Val JA, Wagner W, Kulkarni AV, Sgouros S, Oi S. Safety and diagnostic accuracy of neuroendoscopic biopsies: an international multicenter study. Journal of Neurosurgery. Pediatrics. 11: 704-9. PMID 23581635 DOI: 10.3171/2013.3.Peds12416 |
0.305 |
|
| 2006 |
Wagner W. Why a Focus Session on endoscopic third ventriculostomy in infants Childs Nervous System. 22: 1527-1527. PMID 16944174 DOI: 10.1007/S00381-006-0188-2 |
0.333 |
|
| 2005 |
Wagner W, Koch D. Mechanisms of failure after endoscopic third ventriculostomy in young infants. Journal of Neurosurgery. 103: 43-49. PMID 16122004 DOI: 10.3171/Ped.2005.103.1.0043 |
0.307 |
|
| 2004 |
Koch D, Wagner W. Endoscopic third ventriculostomy in infants of less than 1 year of age: which factors influence the outcome? Childs Nervous System. 20: 405-411. PMID 15118830 DOI: 10.1007/S00381-004-0958-7 |
0.309 |
|
| 2001 |
Schroeder HWS, Wagner W, Tschiltschke W, Gaab MR. Frameless neuronavigation in intracranial endoscopic neurosurgery. Journal of Neurosurgery. 94: 72-79. PMID 11147902 DOI: 10.3171/Jns.2001.94.1.0072 |
0.317 |
|
| 2000 |
Wagner W, Gaab MR, Schroeder HWS, Tschiltschke W. Cranial neuronavigation in neurosurgery: assessment of usefulness in relation to type and site of pathology in 284 patients. Minimally Invasive Neurosurgery. 43: 124-131. PMID 11108110 DOI: 10.1055/S-2000-8332 |
0.338 |
|
| Show low-probability matches. |